Skip to main content

Home/ Business Issues/ Group items tagged #Breast_Cancer

Rss Feed Group items tagged

jacob logan

ESMO 2019: Kisqali shows superior overall survival in breast cancer - 1 views

  •  
    Novartis has said that Kisqali delivered superior overall survival (OS) in the Monaleesa-3 trial, demonstrating more life for postmenopausal human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer patients.
1 - 1 of 1
Showing 20 items per page